Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Toxicol Appl Pharmacol ; 409: 115282, 2020 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-33068622

RESUMEN

Hydraulic fracturing ("fracking") is used in unconventional gas drilling to allow for the free flow of natural gas from rock. Sand in fracking fluid is pumped into the well bore under high pressure to enter and stabilize fissures in the rock. In the process of manipulating the sand on site, respirable dust (fracking sand dust, FSD) is generated. Inhalation of FSD is a potential hazard to workers inasmuch as respirable crystalline silica causes silicosis, and levels of FSD at drilling work sites have exceeded occupational exposure limits set by OSHA. In the absence of any information about its potential toxicity, a comprehensive rat animal model was designed to investigate the bioactivities of several FSDs in comparison to MIN-U-SIL® 5, a respirable α-quartz reference dust used in previous animal models of silicosis, in several organ systems (Fedan, J.S., Toxicol Appl Pharmacol. 00, 000-000, 2020). The present report, part of the larger investigation, describes: 1) a comparison of the physico-chemical properties of nine FSDs, collected at drilling sites, and MIN-U-SIL® 5, a reference silica dust, and 2) a comparison of the pulmonary inflammatory responses to intratracheal instillation of the nine FSDs and MIN-U-SIL® 5. Our findings indicate that, in many respects, the physico-chemical characteristics, and the biological effects of the FSDs and MIN-U-SIL® 5 after intratracheal instillation, have distinct differences.


Asunto(s)
Contaminantes Ocupacionales del Aire/efectos adversos , Exposición por Inhalación/efectos adversos , Pulmón/efectos de los fármacos , Arena/química , Silicosis/etiología , Tráquea/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Polvo , Fracking Hidráulico/métodos , Masculino , Exposición Profesional/efectos adversos , Neumonía/inducido químicamente , Cuarzo/efectos adversos , Ratas , Ratas Sprague-Dawley , Dióxido de Silicio/efectos adversos
2.
Toxicol Mech Methods ; 28(7): 488-498, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29564938

RESUMEN

Acrolein is a reactive electrophilic aldehyde known to cause mitochondrial dysfunction, oxidative stress, and dysregulation of signaling transduction in vitro. Most in vitro systems employ standard cell culture maintenance conditions of 95% air/5% CO2, translating to a culture oxygen tension of approximately 20%, far above most physiological tissues. The purpose of this investigation was to examine whether low-serum, retinoic acid differentiated H9c2 cells were less sensitive to acrolein insult when cultured under reduced oxygen tension. H9c2 cells were maintained separately in 20% and 5% oxygen, differentiated for 5 d, and then exposed to acrolein for 30 min in media containing varying concentrations of tricarboxylic acid and glycolytic substrates, followed by fresh medium replacement. Cells were then assessed for MTT reduction at 2 h and 24 h after acrolein insult. We showed that pyruvate supplementation in combination with lowered oxygen culturing significantly attenuated acrolein-induced viability loss at 24 h. Poly(ADP-ribose) polymerase inhibition and EGTA preferentially provided partial rescue to low oxygen cultures, but not for standard cultures. Collectively, these results offer evidence supporting altered toxicogenic response of H9c2 during physiologically relevant oxygen tension culturing.


Asunto(s)
Acroleína/toxicidad , Cardiotoxinas/toxicidad , Mioblastos Cardíacos/efectos de los fármacos , Oxidantes/toxicidad , Estrés Oxidativo/efectos de los fármacos , Ácido Pirúvico/metabolismo , Animales , Antioxidantes/farmacología , Biomarcadores/metabolismo , Quelantes del Calcio/farmacología , Señalización del Calcio/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Hipoxia de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Resistencia a Medicamentos , Glucólisis/efectos de los fármacos , Mioblastos Cardíacos/citología , Mioblastos Cardíacos/metabolismo , Inhibidores de Poli(ADP-Ribosa) Polimerasas/farmacología , Ratas , Pruebas de Toxicidad Aguda , Ácidos Tricarboxílicos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA